EDC is Now – The Changing

January 5, 2011
Research and Development

Clinical research is rapidly moving toward the electronic environment as more  han half of all studies are conducted utilizing EDC, …

Pfizer headquarters

Pfizer pays $63m for generics portfolio

January 5, 2011
Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables

Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …

GSK’s Dr Anne Phillips moves to Novo Nordisk

January 4, 2011
Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …

Blog footer

Digital Pharma: First big pharma Android apps launched

January 4, 2011
Medical Communications Android, Digital Pharma blog, Novartis, Sanofi-Aventis, apps, ipad, iphone

Big pharma’s smartphone marketing is starting to look beyond Apple’s attention-grabbing iPhone as companies produce the first apps for its …

NICE’s public health role reduced

January 4, 2011
NHS, NHS reforms, NICE, public health, quality standards

NICE’s public health remit has been slimmed down as part of the government’s reforms with the removal of six areas …

Working Life: Astellas Pharma Europe’s chief operating officer

January 4, 2011
Business Services, Sales and Marketing Astellas, Ken Jones, Working Life, recruitment

Ken Jones tells Pharmafocus about how his field is changing, starting with how he found his way into his current …

Achieve More in Phase I Studies

January 4, 2011
Research and Development

Some individuals believe not much has changed in Phase 1 dose escalation studies. A recent review1 that looked at 105 …

Italy: pioneering pay for performance in the age of austerity

January 4, 2011
Sales and Marketing Drug pricing, Italy, cancer drug prices, price cuts

2010 saw Europe beset by economic turmoil, as governments have struggled with the effects of the downturn, including considerable public …

Novartis Holly Springs

Novartis adds R&D unit to new vaccines plant

December 31, 2010
Manufacturing and Production, Research and Development Novartis, pharma manufacturing, vaccines

Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …

US healthcare ‘extreme makeover’ predicted for 2011

December 31, 2010
Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC

Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …

VTE trial boost for Pfizer and BMS’ apixaban

December 31, 2010
Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Pfizer, VTE, apixaban, enoxaparin, venous thromboembolism

Pfizer and Bristol-Myers Squibb’s oral anticoagulant apixaban has shown benefits over a standard injectable treatment for venous thromboembolism in a …

UCB plans €250m plant to meet Cimzia demand

December 29, 2010
Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing

Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …

SHL Expands Range of Automation Solutions for Auto Injector Assembly

December 29, 2010
Manufacturing and Production assembly, auto injector, autoinjector, shl group

December 23, 2010 [Taoyuan, Taiwan]: With an increasing number of drug delivery devices, primarily auto injectors and pen injectors, under …

Pfizer expands Lipitor recall

December 24, 2010
Manufacturing and Production Lipitor, Pfizer, manufacturing compliance, recalls

Pfizer has been forced to recall another 19,000 bottles of its cholesterol-lowering drug Lipitor in the US after consumers reported …

GSK’s patient access scheme for Votrient sways NICE

December 24, 2010
Sales and Marketing GSK, GlaxoSmithKline, NICE, Votrient, pazopanib, rcc, renal cell carcinoma

NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient in final draft guidance after the pharma company offered to implement a …

Blog footer

Digital Pharma: Industry still cautious about social media

December 23, 2010
Medical Communications Deloitte, Digital Pharma blog, doctors' social networks, social media, social networking

Life sciences companies remain cautious about using social networks, such as the healthcare professional community Sermo, largely because of a …

Novartis submits meningococcal vaccine Bexsero for European approval

December 23, 2010
Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine

Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …

2010: Pharma’s year in review

December 23, 2010
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review

2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …

PCTs look to save millions with new cuts

December 23, 2010
Sales and Marketing GP consortia, NHS, NHS cuts, NHS reforms, PCTs, generic prescribing

The NHS in England is cutting back on so-called ‘low priority’ procedures and looking to increase generic prescribing in order …

The Gateway to Local Adoption Series

Latest content